Guinea-Bissau

Areas eligible for SMC and areas where SMC is implemented in 2021

Photo: Guinea-Bissau SMC map

Guinea-Bissau 2021

SMC season

# of children targeted

# of children reached

Coverage

Cycle 1

116,583

112,732

97%

Cycle 2

116,583

110,790

95%

Cycle 3

116,583

108,237

93%

Cycle 4

116583

101815

87%

Children receiving at least 4 cycles

116583

101815

87%

Surveillance de la couverture, la conformité et l'efficacité pendant la campagne du CPS 2020

Photo: Toby Madden / MMV

Monitoring from coverage

  • Coverage is monitored from the third full dose

Monitoring for compliance

  • Direct supervision of distribution teams
  • External evaluation

Evaluating effectiveness

  • Effectiveness is evaluated by monitoring for the decrease in malaria cases in children 3-59 months during the SMC period

Successes, opportunities, challenges and proposed solutions in 2021

Successes

  • Adoption of the door-to-door strategy and observed doses;
  • Timely planning and adapted to the Covid-19 context;
  • Engagement of religious, traditional and community leaders, ASC, RAS and DRS/ERS;
  • Introduction of “tablets” in health areas to collect individual data in eligible regions.

Action steps

  • Carry out a study on the impact assessment of SMC in the regions of Bafatá and Gabú;
  • Implement Real Time Monitoring (RTM) during the SMC campaign;
  • Extend SMC to other health regions with eligibility criteria.

Challenges

  • Reinforcement of interpersonal and mass communication;
  • Strengthening advocacy with traditional and religious administrative authorities;
  • Intensification of the application of drug surveillance;
  • Good coordination at all levels; Extend SMC strategies to other eligible regions;
  • Correct management of adverse reaction cases by ASCs;
     

Proposed solutions

  • Issue awareness messages through media and ASC before and during the SMC campaign;
  • Intensify meetings with community, religious, and administrative leaders;
  • Equip health structures with medicines to deal with cases of adverse reactions.
  • Briefing the campaign situation at all levels;
  • Advocate with technical and financial partners;
  • Train ASC on how to properly manage adverse reaction cases.

Research priorities for 2021

  • Carry out a study on the impact assessment of SMC in the regions of Bafatá and Gabú in December 2022.

Partners

  • Bandim Health Project (PSB) and OPT-SMC project